CDK2 inhibitors and methods of using the same

US12053459B2 · kind B2 · utility

Assignee

• Cedilla Therapeutics, Inc.

Inventors

• Louise Kirman · Cambridge, US
• Carl Eric Schwartz · Lynnfield, US
• Wojtek Michowski · Worthington, US
• Dale Porter · Cambridge, US
• Justin Ripper · Adelaide, AU
• John Thomas Feutrill · Waltham, US

Key dates

• Filing date: Jun 24, 2022
• Grant date: Aug 6, 2024
• Expiry date: Jul 12, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/09
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity of CDK2. The disclosure also provides pharmaceutically acceptable compositions comprising compounds disclosed herein and methods of using said compounds and compositions in the treatment of various disorders related to CDK2 activity.